Thus, it may be that enhanced ORMDL3-dependent modulation of sphingolipid synthesis in CD4+ T cells results in improper allergic or neutrophilic inflammatory responses across the clinical spectrum of asthma phenotypes. The gene discussed is CD4; the disease is asthma.